Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Gout

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Leukemia|October 6, 2001
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drugP W Gout, A R Buckley, C R Simms, et al.
Cancer Genetics and Cytogenetics|April 24, 1999
Malignant progression of rat Nb2 lymphoma cells: chromosomal alterations and metastatic propertiesC K Too, C Lee, S M Sangster, et al.
International Journal of Cancer|August 15, 1984
Vinblastine and vincristine--growth-inhibitory effects correlate with their retention by cultured Nb 2 node lymphoma cellsP W Gout, R L Noble, N Bruchovsky, et al.
Clinical Endocrinology|January 1, 1985
Bioactive forms of serum lactogens: effects of treatment of prolactinoma patients with bromocriptineP S Rennie, J C Prior, N Bruchovsky, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 16, 1984
Bioassay and radioimmunoassay of lactogens in sera from childrenP W Gout, W J Tze, P S Rennie, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 1989
Bioactive recombinant methionyl bovine prolactin: structure-function studies using site-specific mutagenesisD N Luck, P W Gout, C T Beer, et al.
Biochemical and Biophysical Research Communications|November 15, 1994
Prolactin-induced phosphorylation and nuclear translocation of MAP kinase in Nb2 lymphoma cellsA R Buckley, Y P Rao, D J Buckley, et al.
Biotechnology and Applied Biochemistry|March 21, 1998
Synthesis and characterization of recombinant, authentic human prolactin secreted into the periplasmic space of Escherichia coliL Morganti, C R Soares, R Affonso, et al.
Life Sciences|January 1, 1990
Inhibition of hormone-stimulated ornithine decarboxylase activity by lithium chlorideJ F Richards, K Fox, T Peng, et al.
Current Oncology (Toronto, Ont.)|June 23, 2010
Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancerM Lo, V Ling, C Low, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Leukemia|October 6, 2001
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drugP W Gout, A R Buckley, C R Simms, et al.
Cancer Genetics and Cytogenetics|April 24, 1999
Malignant progression of rat Nb2 lymphoma cells: chromosomal alterations and metastatic propertiesC K Too, C Lee, S M Sangster, et al.
International Journal of Cancer|August 15, 1984
Vinblastine and vincristine--growth-inhibitory effects correlate with their retention by cultured Nb 2 node lymphoma cellsP W Gout, R L Noble, N Bruchovsky, et al.
Clinical Endocrinology|January 1, 1985
Bioactive forms of serum lactogens: effects of treatment of prolactinoma patients with bromocriptineP S Rennie, J C Prior, N Bruchovsky, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 16, 1984
Bioassay and radioimmunoassay of lactogens in sera from childrenP W Gout, W J Tze, P S Rennie, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 1989
Bioactive recombinant methionyl bovine prolactin: structure-function studies using site-specific mutagenesisD N Luck, P W Gout, C T Beer, et al.
Biochemical and Biophysical Research Communications|November 15, 1994
Prolactin-induced phosphorylation and nuclear translocation of MAP kinase in Nb2 lymphoma cellsA R Buckley, Y P Rao, D J Buckley, et al.
Biotechnology and Applied Biochemistry|March 21, 1998
Synthesis and characterization of recombinant, authentic human prolactin secreted into the periplasmic space of Escherichia coliL Morganti, C R Soares, R Affonso, et al.
Life Sciences|January 1, 1990
Inhibition of hormone-stimulated ornithine decarboxylase activity by lithium chlorideJ F Richards, K Fox, T Peng, et al.
Current Oncology (Toronto, Ont.)|June 23, 2010
Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancerM Lo, V Ling, C Low, et al.
Pageof 5